S
Sensorion
Biotech & Life Sciences · Montpellier, France · Founded 2009 · IPO 2015
Developing life-transforming therapies for patients with inner ear disorders involving vertigo and hearing loss MoreLess
Sensorion is a biopharmaceutical company founded in 2009, specializing in the development of therapies for debilitating inner ear disorders, such as hearing loss. The company operates in the healthcare and biotechnology markets, focusing on both clinical and preclinical stages of drug development. Sensorion's core clients include patients suffering from sudden sensorineural hearing loss and other inner ear conditions. The business model is centered around research and development, with revenue generated through the commercialization of its drug candidates and potential partnerships or licensing agreements. Sensorion has one clinical stage drug candidate for sudden sensorineural hearing loss and two preclinical gene therapy programs. The company also boasts a cutting-edge inner ear R&D platform, which underscores its commitment to scientific excellence and innovation.
Keywords: biopharmaceutical, inner ear disorders, hearing loss, gene therapy, clinical stage, preclinical, drug development, healthcare, biotechnology, R&D.
Company overview
Sensorion company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2009
- Headquarters
- Montpellier, France
- Employees
- 84
- Open positions
- 5
- Dealroom signal
- 74.2
Valuation & funding
Sensorion funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO EQUITYOther financing | Jan 2026 | $66M | — | Sanofi · Invus · Redmile Group · Cormorant Asset Management | ↗ |
| POST IPO EQUITYOther financing | Apr 2024 | $17M | — | Sofinnova Partners · Invus · Redmile Group | ↗ |
| PRIVATE PLACEMENT VCOther financing | Feb 2024 | $56M | — | Invus · Redmile Group · Aquilo Capital Management · Sofinnova Partners | ↗ |
| PRIVATE PLACEMENT VCOther financing | Aug 2023 | $39M | — | Redmile Group · Sofinnova Partners · Invus | ↗ |
| POST IPO EQUITYOther financing | Dec 2020 | $5.5M | — | Sonova Holding | — |
| PRIVATE PLACEMENT VCOther financing | Sep 2020 | Sofinnova Partners | — | ||
| POST IPO EQUITYOther financing | Sep 2019 | Sofinnova Partners · WuXi AppTec · Invus · 3SBio | ↗ | ||
| POST IPO DEBTDebt | Jun 2019 | Undisclosed | — | ||
| POST IPO EQUITYOther financing | May 2018 | Bpifrance · Alto Invest · Nyenburgh Holding B.V. · Novalis Lifesciences | ↗ | ||
| IPOOther financing | Apr 2015 | Undisclosed | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $24M | — | −$32M | -132.5% |
| 2025 | $0 | — | −$32M | — |
| 2024 | $0 | -100% | −$28M | — |
| 2023 | $5.2M | +17.9% | −$23M | -449.6% |
| 2022 | $4.4M | +20.6% | −$25M | -553.6% |
| 2021 | $3.7M | +74.1% | −$16M | -438.9% |
| 2020 | $2.1M | — | −$9.4M | -445.5% |
Growth signals
Sensorion website traffic
Latest recorded traffic for Sensorion is 7K monthly website visits, up 22.8% over the last three months. Sensorion's team grew 6.3% over the past year.
Hiring
Open positions at Sensorion
Current openings linked to this company in Dealroom.
Comparisons
Sensorion compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Sensorion's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Sensorion has talent and traffic
team presence
In the news
Latest news about Sensorion
Recent press, funding announcements, and product moves mentioning Sensorion — open to read from the original sources.
Market sentiment
What the market is saying about Sensorion
An AI-synthesized read of the highest-engagement posts about Sensorion on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sensorion’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.